dr. james yao discusses the investigation of biomarkers in neuroendocrine tumors
Published 11 years ago • 186 plays • Length 1:36Download video MP4
Download video MP3
Similar videos
-
3:14
the role of biomarkers in neuroendocrine tumors
-
2:14
dr. james c. yao on everolimus in pancreatic neuroendocrine tumors
-
2:01
dr. james yao on everolimus in advanced pancreatic neuroendocrine tumors
-
3:20
emerging therapies in neuroendocrine tumors (nets)
-
35:25
neuroendocrine cancer - common diet myths
-
25:15
a spotlight on gastric neuroendocrine tumours
-
24:37
what causes alzheimer's disease: amyloid vs tau
-
37:26
1. nets overview, james yao, md; md anderson, 2018 houston conference
-
3:39
targeted therapies in neuroendocrine tumors
-
5:32
clinical and biological distinctions in neuroendocrine tumors
-
4:39
introduction and overview of the diagnosis and characterization of neuroendocrine tumors
-
1:25
meet james yao, m.d.
-
6:52
neuroendocrine tumors: disease factors influencing the initial treatment approach
-
7:48
effect of everolimus on markers of angiogenesis in patients with advanced pnet
-
5:28
prognostic indicators in pancreatic neuroendocrine tumors
-
6:18
role of somatostatin analogs in neuroendocrine tumors
-
7:36
systemic treatment options and sequencing in pnets
-
6:22
the battle against rare cancers in europe - part 1
-
1:52
dr. yao on health-related qol in patients with neuroendocrine tumors
-
8:45
sequencing decisions in neuroendocrine tumors
-
3:16
neuroendocrine tumors: goals of therapy with somatostatin analogs
-
5:38
symptoms types and diagnosis of neuroendocrine tumours (nets)